Loading…
← CockpitCompetitor Analysis › 2201.T Morinaga & Co., Ltd.Open in the cockpit ↗

Morinaga & Co., Ltd.2201.TCompetitor analysis, valuation and peers

Japan · JPY·Consumer Staples›Food: Specialty/Candy

Japanese confectionery maker known for chocolate, Hi-Chew candy and biscuits, distinct from dairy peer Morinaga Milk.

≈ Japan's Hershey/Mars for confectioneryMomentum neutral 44
Mkt cap
$1.28B
US dollars, full cap
Free float
80%
of shares outstanding
$/day
$5.51M
20-day average traded
Fwd P/E
12.3×
forward earnings
ROIC−WACC
+4.1 pp
WACC 5.0%
Hurdle
-13 pp
Req g minus delivered
Next earnings
6 days
12 Nov 2026
Close · JPY¥2,449
1D-3.9%
1W+3.7%
1M+3.4%
3M-6.7%
6M-8.5%
YTD-7.9%
1Y-7.5%
ATR %1.9%
52w lowhigh15.4% off high

What Morinaga & does

Japanese confectionery maker known for chocolate, Hi-Chew candy and biscuits, distinct from dairy peer Morinaga Milk.

Sells packaged sweets to wholesalers who supply supermarkets and convenience stores, so shelf space and repeat impulse purchases drive sales. Overseas, Hi-Chew is sold through local subsidiaries, with the US the main market, and it has become the group's best-known export.

In one line: Japan's Hershey/Mars for confectionery.

Products and services

  • Chocolate
  • Hi-Chew candy
  • Biscuits/snacks

Customers

  • Retail grocery/convenience store consumers

Where it sits in the supply chain

  • Food & beverage
  • Confectionery
  • Chocolate, candy, biscuits

What could go right

  • Hi-Chew overseas growth (US/Asia)

What could go wrong

  • Cocoa/sugar input cost inflation
  • Confectionery category competition

Moat: narrow (brand, distribution). Long-standing confectionery brands, with Hi-Chew gaining global distribution.

Headquarters: Tokyo, Japan · Founded: 1899 · Employees: 3,222

Named competitors

Morinaga & at a glance

Size Morinaga & (2201.T) is a Japan Consumer Staples company (Food: Specialty/Candy) with a market value of $1.28B, the 632nd largest of 1,379 Japan companies the cockpit tracks. Shares closed at ¥2,449 on 6 Nov 2026.

Performance Over six months the shares fell 8.5%, against -19.9% for the median peer and +1.8% for the Japan market (cap-weighted) — 8th highest of 20 in its peer set.

Growth Revenue grew 3.3% over the last twelve months (peer median +7.8%); the operating margin is 8.9% (peer median 6.4%).

Valuation It trades at 12.3× forward earnings against a peer median of 24.0× (5th cheapest of 18).

Price implies For today's price to make sense, revenue must grow about -6% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is -13 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 4.1 points above its cost of capital (5.0% WACC).

Next results Next results expected around 12 Nov 2026 (exchange calendar; dates can move).

Relative performance

809010011 May 202611 Aug 20266 Nov 20262201.T 91Peer median 84
Six months, rebased to 100: Morinaga & against the median of its 20 peers (local-currency closes).

Morinaga & financials

Reported figures in JPY; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue¥240B¥237B¥229B¥213B¥194B
Revenue growth—+3%+7%+10%—
Gross profit¥96.6B¥95.0B¥90.0B¥86.7B¥76.6B
EBITDA¥32.0B¥32.6B¥31.2B¥29.7B¥25.3B
Net income¥17.2B¥17.8B¥17.7B¥15.2B¥10.1B
Free cash flown/a¥6.65B-¥2.82B¥21.1B-¥16.3B
Capital expendituren/a¥17.7B¥15.9B¥10.5B¥13.6B
Total debt¥41.0B¥20.0B¥20.2B¥20.3B¥20.4B

Quarterly statements and history in the cockpit →

Morinaga & competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-25%0%+25%+50%-20%-10%0%+10%BIKAJIMANORAMA054626020336ITM600929CCL002891FLO603027200128116001276008660018002201.T6-month return →1-month return →
Up and to the right = strong over both horizons. Morinaga & is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%20×40×60×BIKAJIMANORAMA054660501626020336ITM600929CCL004990002891FLO60302728116008662201.TRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Morinaga & is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%+40%-20%0%20%40%BIKAJIMANORAMA60501626020336CCLFLO6030270018002201.TGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Morinaga & is the large dot.

Morinaga & competitors and peer comparison

Head to head with its named competitors (2201.T vs 2206.T vs 2269.T)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Morinaga & 2201.T$1.28B-8%+3%9%12.3×-5.7%
Ezaki Glico 2206.T$2.07B-11%+10%3%35.7×7.5%
Meiji 2269.T$7.35B+14%+4%8%17.2×n/a

How Morinaga & compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Morinaga & against its 20 peers (data as of 6 Nov 2026)
Measure2201.TPeer medianRank in peer set
1-month return+3.4%-1.4%5th highest of 21
6-month return-8.5%-19.9%8th highest of 20
Distance from 52-week high-15.4%-32.6%5th highest of 21
Revenue growth (TTM)+3.3%+7.8%10th lowest of 21
Operating margin8.9%6.4%9th highest of 21
Forward P/E12.3×24.0×5th cheapest of 18
Growth the price implies (Req g, 7 yrs)-5.7%5.9%3rd least demanding of 11
Growth delivered (Del g)+7.1%+10.2%3rd lowest of 11
Hurdle (Req g minus delivered)-12.8 pp-9.5 pp4th least demanding of 11
ROIC minus cost of capital+4.1 pp-0.4 pp6th highest of 21
EV / EBITDA6.8×9.9×4th cheapest of 13
Net debt / EBITDA0.5×0.7×6th least indebted of 14

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Morinaga & 2201.TJapan$1.28B-8%+3%9%12.3×-5.7%+7.1%
Bikaji Foods International BIKAJI.NSIndia$1.27B-29%+14%10%37.4×38.6%+17.5%
Manorama Industries MANORAMA.NSIndia$1.31B+22%+60%24%39.3×33.4%+46.9%
Fufeng 0546.HKHong Kong$1.31B-37%+1%4%7.4×n/an/a
Shandong Bailong Chuangyuan Bio-Tech 605016.SSChina$1.24B-28%+19%32%18.4×8.8%+22.5%
Nisshin OilliO 2602.TJapan$1.22B+13%+8%3%18.0×3.1%+10.5%
Huabao International 0336.HKHong Kong$1.34B-25%+13%3%25.3×16.2%-2.7%
Italmobiliare ITM.MIItaly$1.20B-8%+8%14%12.0×n/an/a
Snowsky Salt Industry 600929.SSChina$1.20B-29%+32%1%54.7×n/an/a
CCL Products (India) CCL.NSIndia$1.37B-20%+24%13%25.8×17.9%+29.1%
Lotte 004990.KSSouth Korea$1.18B-27%+1%2%69.5×n/an/a
Yantai China Pet Foods 002891.SZChina$1.39B-15%+21%4%32.6×n/an/a
Flowers Foods FLOUnited States$1.42B-20%+2%6%8.8×-7.6%+3.7%
Qianhe Condiment & Food 603027.SSChina$1.43B-21%-6%14%23.9×3.1%+8.8%
Chacha Food 002557.SZChina$1.46B-17%+8%8%15.8×n/an/a
Jiangxi Qiyunshan Food 2797.HKHong Kong$1.10Bn/a-7%17%n/an/an/a
NIPPN 2001.TJapan$1.50B+8%+2%5%11.3×n/an/a
Kagome 2811.TJapan$1.51B+3%+3%7%24.0×2.2%+10.0%
JinJian Cereals Industry 600127.SSChina$1.08B+64%+1%-1%n/an/an/a
Star Lake Bioscience 600866.SSChina$1.07B-26%-3%0%37.2×n/an/a
ORION 001800.KSSouth Korea$1.06B-4%+15%15%n/a-16.5%+8.3%

Questions

Who are Morinaga &'s main competitors?
Named competitors: Ezaki Glico (2206.T), Meiji Holdings (2269.T). The cockpit's measured peer set (industry) also includes Bikaji Foods International (BIKAJI.NS), Manorama Industries (MANORAMA.NS), Fufeng (0546.HK), Shandong Bailong Chuangyuan Bio-Tech (605016.SS), Nisshin OilliO (2602.T), Huabao International (0336.HK).
Is Morinaga & expensive compared with its peers?
On forward p/e it trades at 12.3× against a peer median of 24.0×, 5th cheapest of 18 in its peer set. For today's price to make sense, revenue must grow about -6% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is -13 pp: the price already allows for a slowdown.
How has Morinaga & stock performed?
Over six months to 6 Nov 2026 the shares returned -8.5% against -19.9% for the median peer; over one year -7.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.